Ecgonine Methyl Ester

Ecgonine Methyl Ester at a Glance

Ecgonine methyl ester (EME, also called methylecgonine) is a small tropane alkaloid with two identities. In the plant, it is a minor constituent of coca (Erythroxylum), detected in both leaf and seed alongside the dominant alkaloid cocaine ^{1,9Reference 1Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →Reference 9Novak M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}. In the body, it is one of the two major metabolites of cocaine — the product of the enzymatic hydrolysis route, formed when the plasma enzyme butyrylcholinesterase cleaves the benzoyl ester off cocaine ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}.

That second identity is what makes it worth its own page. Cocaine is broken down along two parallel routes: an enzymatic one that yields EME, and a spontaneous (non-enzymatic) chemical one that yields benzoylecgonine. EME is not the same molecule as ecgonine — it is ecgonine’s methyl ester, one hydrolysis step upstream of the free acid.

Pharmacologically EME is a quiet molecule. Unlike its parent it does not block monoamine reuptake or produce cocaine’s stimulant or local-anaesthetic effects ^{6Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}; the only activity reliably attributed to it is a mild vasodilation, shown in animal models ^{3,4Reference 3Pane MA et al. · 1997Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheepView study →Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →}. Its main practical role today is forensic — as a marker confirming cocaine exposure in urine and hair ^{5,6Reference 5Ramírez Fernández MDM et al. · 2025Establishing effective interpretation criteria in hair analysis to distinguish between passive and active cocaine exposureView study →Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}.

The Esterase-Route Cocaine Metabolite

The single most useful fact about EME is how it is made. When cocaine enters the body it is cleared along two hydrolytic pathways that each remove one of cocaine’s two ester groups ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}:

• Enzymatic route → ecgonine methyl ester (EME). The plasma enzyme butyrylcholinesterase (also called pseudocholinesterase or plasma cholinesterase) hydrolyses the benzoyl ester, leaving the methyl ester intact. This is the route that produces EME ^{2,4Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →}.
• Non-enzymatic route → benzoylecgonine. Spontaneous chemical hydrolysis at physiological pH removes the methyl ester instead, leaving benzoylecgonine. This route needs no enzyme ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}.

Both metabolites then converge on ecgonine, the fully hydrolysed core, once the second ester is also cleaved. Together EME and benzoylecgonine account for the large majority of a cocaine dose; the minor remainder is oxidised (e.g. to norcocaine) or, with co-ingested alcohol, transesterified to cocaethylene ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}.

The enzymatic origin matters clinically as well as forensically. Because butyrylcholinesterase governs the EME route, people with low or atypical cholinesterase activity clear cocaine more slowly toward EME, shifting the metabolite balance — one reason cocaine sensitivity varies between individuals ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}. It has also motivated the therapeutic idea of giving exogenous cholinesterase to accelerate cocaine breakdown, which in animal models both lowers active-metabolite load and raises EME ^{4Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →}.

What It's Used For

EME’s pharmacology is best understood as the absence of cocaine’s pharmacology, plus one modest vascular action. The evidence is almost entirely animal or in-vitro, on the isolated metabolite rather than on any coca preparation.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every row here rests on the isolated metabolite in animal/analytical work, not on coca preparations, so read the per-row basis.

01Forensic Exposure MarkerPromising55%Established analytical use in urine/hair after cocaine or coca-tea intake ^{5,6,7Reference 5Ramírez Fernández MDM et al. · 2025Establishing effective interpretation criteria in hair analysis to distinguish between passive and active cocaine exposureView study →Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →Reference 7Rubio NC et al. · 2026From vial to injector: stability, degradation, and surface interactions of non-derivatized ecgonine methyl ester in GC-MSView study →}

02Cerebral / Vascular EffectShaky30%Animal vasodilation + mouse anti-lethality ^{3,4Reference 3Pane MA et al. · 1997Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheepView study →Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →}

03Monoamine / Stimulant ActivityShaky8%Essentially inactive vs. cocaine in alkaloid screens ^{6Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}

Mechanisms

The load-bearing point is subtractive: strip the benzoyl group off cocaine and you remove the reuptake-blocking pharmacophore, leaving a quiet molecule whose only reproducible action is mild vasodilation ^{3,4,6Reference 3Pane MA et al. · 1997Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheepView study →Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}.

Pharmacokinetics

EME is not administered as a drug — its pharmacokinetics are the metabolite kinetics of cocaine. After cocaine exposure, butyrylcholinesterase-driven hydrolysis routes a large fraction of the dose to EME, in parallel with spontaneous formation of benzoylecgonine ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}. EME is water-soluble and renally excreted; in the coca-tea study its urinary detection window reached roughly 60 hours, slightly shorter than benzoylecgonine’s ~70 hours ^{6Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}. The balance between the two metabolites is enzyme-dependent — reduced or atypical butyrylcholinesterase activity slows the EME route and alters the metabolite ratio ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}. In vitro, EME can dehydrate to anhydroecgonine methyl ester (AEME), a preanalytical caveat for its measurement ^{7Reference 7Rubio NC et al. · 2026From vial to injector: stability, degradation, and surface interactions of non-derivatized ecgonine methyl ester in GC-MSView study →}.

Clinical Trials

There are no clinical trials of ecgonine methyl ester as a therapeutic agent. It appears in the literature only as a metabolite/analyte in cocaine pharmacokinetic and forensic studies, and mechanistically in animal work.

Last checked: July 2026.

Isolate vs. Plant Studies

Every EME finding here is on the isolated molecule — the metabolite in blood, urine or hair, or purified EME injected into animals ^{3,4,5,6,7Reference 3Pane MA et al. · 1997Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheepView study →Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →Reference 5Ramírez Fernández MDM et al. · 2025Establishing effective interpretation criteria in hair analysis to distinguish between passive and active cocaine exposureView study →Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →Reference 7Rubio NC et al. · 2026From vial to injector: stability, degradation, and surface interactions of non-derivatized ecgonine methyl ester in GC-MSView study →}. No study tests “coca leaf for its EME content” as an intervention, because in coca EME is a minor tropane dwarfed by cocaine ^{1,9Reference 1Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →Reference 9Novak M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}: any pharmacology of a coca preparation is dominated by cocaine, not EME. So the isolate-vs-plant distinction here is unusually clean — the plant supplies EME only in trace amounts and as an exposure marker, while the (modest) pharmacology belongs entirely to the purified metabolite.

Prevalence in Nature

EME is a genuine native alkaloid of coca, not merely a laboratory or metabolic artefact. Modern forensic GC-MS of Erythroxylum coca var. coca seeds identified EME among the seed tropanes, distinct from cocaine and from the seed-characteristic methylecgonidine ^{1Reference 1Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}; it is likewise reported in leaf analyses of the Erythroxylum alkaloid complex ^{9Reference 9Novak M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}. In all of these, EME is a minor component — coca’s alkaloid fraction is dominated by cocaine (roughly 0.5–1% of leaf dry weight), with EME and the other tropanes present at far lower levels ^{9Reference 9Novak M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}.

It also turns up wherever coca leaf is processed into a product. In a chemically analysed bottle of 19th-century Mariani coca wine, EME was measured at ~130 ng/mL alongside cocaine and benzoylecgonine — direct evidence that the drink really did contain macerated coca leaf ^{8Reference 8Arbouche N et al. · 2024Mariani wine: what’s really in it? Analysis of the most popular tonic drink of the 19th century after 100 years of storageView study →}. And in coca tea, EME is one of the alkaloids ingested directly and subsequently excreted ^{6Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}.

Beyond the plant, EME’s other major “source” is endogenous — it is generated in the body of anyone who has taken cocaine, via the butyrylcholinesterase route described above ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}.

Discovery & Synthesis

EME has been recognised as a cocaine hydrolysis product since the classical era of coca chemistry — cocaine is the benzoyl ester of ecgonine methyl ester, so partial hydrolysis to EME (and, further, to ecgonine) has been understood for as long as cocaine’s structure has. Its identity as a native constituent of the coca plant itself, rather than only a breakdown product, was cemented by modern forensic chemistry — notably Casale and colleagues’ GC-MS characterisation of the alkaloids in Erythroxylum coca seeds, which reported EME among the naturally occurring seed tropanes ^{1Reference 1Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}.

There is no meaningful “manufacture” story: EME is not produced commercially as a therapeutic. It exists as an analytical reference standard (and isotopically labelled internal standard) for forensic toxicology laboratories, where it is prepared/handled purely for cocaine-metabolite quantification ^{7Reference 7Rubio NC et al. · 2026From vial to injector: stability, degradation, and surface interactions of non-derivatized ecgonine methyl ester in GC-MSView study →}, and it forms continuously in vivo as a metabolite of cocaine ^{2Reference 2Roque Bravo R et al. · 2022Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse patternView study →}.

Patents: not yet researched.

Toxicity & Safety

EME carries a low flag — the lowest of the coca tropanes discussed here. That rating reflects its pharmacology: it lacks cocaine’s monoamine-reuptake blockade, stimulant drive and sodium-channel anaesthesia ^{6Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}, the actions responsible for cocaine’s cardiovascular and neurological toxicity. In animal work EME is not only non-toxic at the doses used but mildly protective against cocaine lethality, consistent with vasodilation ^{4Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →}. The important caveats are contextual rather than intrinsic.

Safety at a Glance

✅ Low / no toxicity

• Low intrinsic activity. As an isolated metabolite EME lacks cocaine’s stimulant, anaesthetic and reuptake-blocking effects, and is a mild vasodilator in animal models ^{3,4,6Reference 3Pane MA et al. · 1997Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheepView study →Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}.
• Its presence signals cocaine exposure. EME in urine or hair is a forensic marker of cocaine or coca-leaf intake — the legal and clinical weight sits with the exposure it reveals, not with EME’s own toxicity ^{5,6Reference 5Ramírez Fernández MDM et al. · 2025Establishing effective interpretation criteria in hair analysis to distinguish between passive and active cocaine exposureView study →Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}.
• A regulated coca alkaloid. As a tropane of the coca plant and a cocaine metabolite, EME falls within controlled-substance frameworks; it is a laboratory reference material, not a consumer ingredient.
• No human safety dataset. There is no dedicated human toxicology of pure EME; the “low” rating is inferred from its inactivity and animal data, not from clinical exposure studies.

Dosage

There is no therapeutic dose of ecgonine methyl ester — it is not a medicine. The only figures in the literature are experimental animal doses used to probe its pharmacology (e.g. 2.5 mg/kg IV in neonatal sheep for the vasodilation study ^{3Reference 3Pane MA et al. · 1997Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheepView study →}; 50 mg/kg IP in mice for the anti-lethality study ^{4Reference 4Hoffman RS et al. · 2004AnimalEcgonine methyl ester protects against cocaine lethality in miceView study →}), and analyte concentrations measured in biological samples after cocaine or coca-leaf exposure (urine EME up to ~1,738 ng/mL after coca tea ^{6Reference 6Feisthauer E et al. · 2022Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testingView study →}). These are research and forensic measurements, not a personal recommendation.

References

1. Casale JF, Toske SG, Colley VL (2005). Alkaloid content of the seeds from Erythroxylum coca var. coca. Journal of Forensic Sciences. https://pubmed.ncbi.nlm.nih.gov/16382835/
2. Roque Bravo R, et al. (2022). Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse pattern. Toxins (Basel). https://pubmed.ncbi.nlm.nih.gov/35448887/
3. Pane MA, Traystman RJ, Gleason CA (1997). Ecgonine methyl ester, a major cocaine metabolite, causes cerebral vasodilation in neonatal sheep. Pediatric Research. https://pubmed.ncbi.nlm.nih.gov/9167194/
4. Hoffman RS, Kaplan JL, Hung OL, Goldfrank LR (2004). Ecgonine methyl ester protects against cocaine lethality in mice. Journal of Toxicology. Clinical Toxicology. https://pubmed.ncbi.nlm.nih.gov/15461242/
5. Ramírez Fernández MDM, et al. (2025). Establishing effective interpretation criteria in hair analysis to distinguish between passive and active cocaine exposure. Drug Testing and Analysis. https://pubmed.ncbi.nlm.nih.gov/38574760/
6. Feisthauer E, et al. (2022). Analysis of cocaine and its metabolites in urine after consumption of coca tea by five subjects and subsequent hair testing. Journal of Analytical Toxicology. https://pubmed.ncbi.nlm.nih.gov/33277893/
7. Rubio NC, et al. (2026). From vial to injector: stability, degradation, and surface interactions of non-derivatized ecgonine methyl ester in GC-MS. Journal of Chromatography B. https://pubmed.ncbi.nlm.nih.gov/42001807/
8. Arbouche N, de Lestrange A, Raul JS, Kintz P (2024). Mariani wine: what’s really in it? Analysis of the most popular tonic drink of the 19th century after 100 years of storage. Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/37866081/
9. Novak M, Salemink CA, Khan I (1984). Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatense. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/6379304/

View all 9 references▾